European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Influence of Grape Consumption on the Human Microbiome June 26, 2023 Improving Growth Dynamics of Faecalibacterium prausnitzii by Exposure to Prebiotics February 25, 2026 Australian Trial Examines Impact of HAMSAB (Resistant Starch-based) Prebiotic and Patients with High Blood Pressure January 11, 2023
Improving Growth Dynamics of Faecalibacterium prausnitzii by Exposure to Prebiotics February 25, 2026
Australian Trial Examines Impact of HAMSAB (Resistant Starch-based) Prebiotic and Patients with High Blood Pressure January 11, 2023